Global Soliris Intravenous Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Soliris Intravenous Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Soliris Intravenous report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Soliris Intravenous market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from PNH and AHUS are the major drivers for the industry.
In the last several years, Asia-Pacific market of Soliris Intravenous developed rapidly.Japan is the largest consumption place. Market competition is not intense.The FDA will not approve biosimilar applications for Soliris Intravenous before 16 March 2019; there is an ongoing debate over the length of exclusivity periods.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Soliris Intravenous market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
PNH
AHUS
Other
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Each chapter of the report provides detailed information for readers to understand the Soliris Intravenous market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Soliris Intravenous, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Soliris Intravenous industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Soliris Intravenous in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Soliris Intravenous introduction, etc. Soliris Intravenous Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Soliris Intravenous market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Soliris Intravenous report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Soliris Intravenous market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from PNH and AHUS are the major drivers for the industry.
In the last several years, Asia-Pacific market of Soliris Intravenous developed rapidly.Japan is the largest consumption place. Market competition is not intense.The FDA will not approve biosimilar applications for Soliris Intravenous before 16 March 2019; there is an ongoing debate over the length of exclusivity periods.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Soliris Intravenous market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
AHUS
Other
Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Each chapter of the report provides detailed information for readers to understand the Soliris Intravenous market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Soliris Intravenous, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Soliris Intravenous industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Soliris Intravenous in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Soliris Intravenous introduction, etc. Soliris Intravenous Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Soliris Intravenous market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices